annual D&A:
$75.66M-$160.93M(-68.02%)Summary
- As of today (May 21, 2025), PTCT annual depreciation & amortization is $75.66 million, with the most recent change of -$160.93 million (-68.02%) on December 31, 2024.
- During the last 3 years, PTCT annual D&A has risen by +$11.53 million (+17.98%).
- PTCT annual D&A is now -68.02% below its all-time high of $236.59 million, reached on December 31, 2023.
Performance
PTCT Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$7.22M+$457.00K(+6.76%)Summary
- As of today (May 21, 2025), PTCT quarterly depreciation & amortization is $7.22 million, with the most recent change of +$457.00 thousand (+6.76%) on March 1, 2025.
- Over the past year, PTCT quarterly D&A has dropped by -$48.17 million (-86.96%).
- PTCT quarterly D&A is now -91.05% below its all-time high of $80.70 million, reached on December 31, 2023.
Performance
PTCT quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$27.49M-$48.17M(-63.67%)Summary
- As of today (May 21, 2025), PTCT TTM depreciation & amortization is $27.49 million, with the most recent change of -$48.17 million (-63.67%) on March 1, 2025.
- Over the past year, PTCT TTM D&A has dropped by -$221.67 million (-88.97%).
- PTCT TTM D&A is now -88.97% below its all-time high of $249.16 million, reached on March 31, 2024.
Performance
PTCT TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
PTCT Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -68.0% | -87.0% | -89.0% |
| 3 y3 years | +18.0% | -72.6% | -64.2% |
| 5 y5 years | +135.1% | -21.8% | -20.0% |
PTCT Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -68.0% | +18.0% | -91.0% | +11.3% | -89.0% | at low |
| 5 y | 5-year | -68.0% | +135.1% | -91.0% | +11.3% | -89.0% | at low |
| alltime | all time | -68.0% | +3285.4% | -91.0% | +1232.3% | -89.0% | +3829.3% |
PTCT Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $7.22M(+6.8%) | $27.49M(-63.7%) |
| Dec 2024 | $75.66M(-68.0%) | $6.76M(+4.3%) | $75.66M(-49.4%) |
| Sep 2024 | - | $6.49M(-7.6%) | $149.60M(-27.1%) |
| Jun 2024 | - | $7.02M(-87.3%) | $205.17M(-17.7%) |
| Mar 2024 | - | $55.40M(-31.4%) | $249.16M(+5.3%) |
| Dec 2023 | $236.59M(+83.6%) | $80.70M(+30.1%) | $236.59M(+21.5%) |
| Sep 2023 | - | $62.05M(+21.7%) | $194.75M(+16.5%) |
| Jun 2023 | - | $51.01M(+19.1%) | $167.17M(+15.0%) |
| Mar 2023 | - | $42.83M(+10.2%) | $145.35M(+12.8%) |
| Dec 2022 | $128.84M(+100.9%) | $38.87M(+12.7%) | $128.84M(+18.4%) |
| Sep 2022 | - | $34.48M(+18.2%) | $108.78M(+19.5%) |
| Jun 2022 | - | $29.18M(+10.9%) | $91.06M(+18.5%) |
| Mar 2022 | - | $26.31M(+39.9%) | $76.86M(+19.8%) |
| Dec 2021 | $64.13M(+47.5%) | $18.81M(+12.3%) | $64.13M(+11.1%) |
| Sep 2021 | - | $16.75M(+11.8%) | $57.73M(+9.7%) |
| Jun 2021 | - | $14.99M(+10.3%) | $52.62M(+10.0%) |
| Mar 2021 | - | $13.59M(+9.6%) | $47.84M(+10.0%) |
| Dec 2020 | $43.49M(+35.1%) | $12.40M(+6.5%) | $43.49M(+7.7%) |
| Sep 2020 | - | $11.64M(+14.0%) | $40.37M(+9.5%) |
| Jun 2020 | - | $10.21M(+10.6%) | $36.87M(+7.3%) |
| Mar 2020 | - | $9.23M(-0.5%) | $34.36M(+6.8%) |
| Dec 2019 | $32.18M(+23.4%) | $9.28M(+13.9%) | $32.18M(+8.4%) |
| Sep 2019 | - | $8.14M(+5.7%) | $29.67M(+3.7%) |
| Jun 2019 | - | $7.70M(+9.1%) | $28.60M(+5.5%) |
| Mar 2019 | - | $7.06M(+4.3%) | $27.12M(+4.0%) |
| Dec 2018 | $26.09M | $6.77M(-4.3%) | $26.09M(+3.3%) |
| Sep 2018 | - | $7.07M(+13.7%) | $25.25M(-11.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | $6.22M(+3.3%) | $28.48M(+23.3%) |
| Mar 2018 | - | $6.02M(+1.4%) | $23.09M(+30.6%) |
| Dec 2017 | $17.68M(+437.4%) | $5.94M(-42.3%) | $17.68M(+40.8%) |
| Sep 2017 | - | $10.29M(+1131.5%) | $12.56M(+308.5%) |
| Jun 2017 | - | $836.00K(+36.6%) | $3.07M(+0.7%) |
| Mar 2017 | - | $612.00K(-24.7%) | $3.05M(-7.2%) |
| Dec 2016 | $3.29M(+14.4%) | $813.00K(0.0%) | $3.29M(+0.5%) |
| Sep 2016 | - | $813.00K(-0.2%) | $3.27M(+1.6%) |
| Jun 2016 | - | $815.00K(-4.0%) | $3.22M(+4.2%) |
| Mar 2016 | - | $849.00K(+6.5%) | $3.09M(+7.5%) |
| Dec 2015 | $2.88M(+28.7%) | $797.00K(+4.9%) | $2.88M(+9.7%) |
| Sep 2015 | - | $760.00K(+10.9%) | $2.62M(+9.0%) |
| Jun 2015 | - | $685.00K(+8.0%) | $2.40M(+5.4%) |
| Mar 2015 | - | $634.00K(+17.0%) | $2.28M(+2.1%) |
| Dec 2014 | $2.23M(-6.7%) | $542.00K(-0.2%) | $2.23M(-1.9%) |
| Sep 2014 | - | $543.00K(-3.4%) | $2.28M(-2.0%) |
| Jun 2014 | - | $562.00K(-4.4%) | $2.32M(-1.5%) |
| Mar 2014 | - | $588.00K(+0.5%) | $2.36M(-1.5%) |
| Dec 2013 | $2.40M(-11.4%) | $585.00K(-0.7%) | $2.40M(-2.9%) |
| Sep 2013 | - | $589.00K(-1.3%) | $2.47M(-3.1%) |
| Jun 2013 | - | $597.00K(-4.5%) | $2.54M(-3.2%) |
| Mar 2013 | - | $625.00K(-4.6%) | $2.63M(-2.8%) |
| Dec 2012 | $2.70M(-5.8%) | $655.30K(-1.8%) | $2.70M(+32.0%) |
| Sep 2012 | - | $667.40K(-2.1%) | $2.05M(+48.3%) |
| Jun 2012 | - | $681.60K(-2.6%) | $1.38M(+97.4%) |
| Mar 2012 | - | $699.60K | $699.60K |
| Dec 2011 | $2.87M | - | - |
FAQ
- What is PTC Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for PTC Therapeutics?
- What is PTC Therapeutics annual D&A year-on-year change?
- What is PTC Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for PTC Therapeutics?
- What is PTC Therapeutics quarterly D&A year-on-year change?
- What is PTC Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for PTC Therapeutics?
- What is PTC Therapeutics TTM D&A year-on-year change?
What is PTC Therapeutics annual depreciation & amortization?
The current annual D&A of PTCT is $75.66M
What is the all time high annual D&A for PTC Therapeutics?
PTC Therapeutics all-time high annual depreciation & amortization is $236.59M
What is PTC Therapeutics annual D&A year-on-year change?
Over the past year, PTCT annual depreciation & amortization has changed by -$160.93M (-68.02%)
What is PTC Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of PTCT is $7.22M
What is the all time high quarterly D&A for PTC Therapeutics?
PTC Therapeutics all-time high quarterly depreciation & amortization is $80.70M
What is PTC Therapeutics quarterly D&A year-on-year change?
Over the past year, PTCT quarterly depreciation & amortization has changed by -$48.17M (-86.96%)
What is PTC Therapeutics TTM depreciation & amortization?
The current TTM D&A of PTCT is $27.49M
What is the all time high TTM D&A for PTC Therapeutics?
PTC Therapeutics all-time high TTM depreciation & amortization is $249.16M
What is PTC Therapeutics TTM D&A year-on-year change?
Over the past year, PTCT TTM depreciation & amortization has changed by -$221.67M (-88.97%)